vs
Side-by-side financial comparison of NETSTREIT Corp. (NTST) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $57.1M, roughly 1.3× NETSTREIT Corp.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 24.3%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 20.1%).
NETSTREIT Corp. is a US-headquartered real estate investment trust (REIT) that specializes in acquiring and operating a diversified portfolio of single-tenant net lease commercial properties. Its asset portfolio covers retail, industrial and office categories, primarily catering to investment-grade corporate tenants across the United States market.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
NTST vs PBYI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $57.1M | $75.5M |
| Net Profit | $5.7M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | 34.1% | 22.7% |
| Net Margin | 10.0% | — |
| Revenue YoY | 24.3% | 27.7% |
| Net Profit YoY | 235.9% | — |
| EPS (diluted) | $0.32 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $57.1M | — | ||
| Q4 25 | $52.5M | $75.5M | ||
| Q3 25 | $48.3M | $54.5M | ||
| Q2 25 | $48.3M | $52.4M | ||
| Q1 25 | $45.9M | $46.0M | ||
| Q4 24 | $44.1M | $59.1M | ||
| Q3 24 | $41.4M | $80.5M | ||
| Q2 24 | $39.6M | $47.1M |
| Q1 26 | $5.7M | — | ||
| Q4 25 | $1.3M | — | ||
| Q3 25 | $618.0K | $8.8M | ||
| Q2 25 | $3.3M | $5.9M | ||
| Q1 25 | $1.7M | $3.0M | ||
| Q4 24 | $-5.4M | — | ||
| Q3 24 | $-5.3M | $20.3M | ||
| Q2 24 | $-2.3M | $-4.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% |
| Q1 26 | 34.1% | — | ||
| Q4 25 | 2.6% | 22.7% | ||
| Q3 25 | 1.3% | 17.6% | ||
| Q2 25 | 6.8% | 12.7% | ||
| Q1 25 | 3.7% | 8.7% | ||
| Q4 24 | -12.3% | 22.6% | ||
| Q3 24 | -12.8% | 27.4% | ||
| Q2 24 | -5.8% | -4.6% |
| Q1 26 | 10.0% | — | ||
| Q4 25 | 2.5% | — | ||
| Q3 25 | 1.3% | 16.2% | ||
| Q2 25 | 6.8% | 11.2% | ||
| Q1 25 | 3.7% | 6.5% | ||
| Q4 24 | -12.3% | — | ||
| Q3 24 | -12.8% | 25.2% | ||
| Q2 24 | -5.8% | -9.6% |
| Q1 26 | $0.32 | — | ||
| Q4 25 | $0.01 | $0.26 | ||
| Q3 25 | $0.01 | $0.17 | ||
| Q2 25 | $0.04 | $0.12 | ||
| Q1 25 | $0.02 | $0.06 | ||
| Q4 24 | $-0.07 | $0.40 | ||
| Q3 24 | $-0.07 | $0.41 | ||
| Q2 24 | $-0.03 | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $1.5B | $130.3M |
| Total Assets | $2.8B | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M |
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | $22.7M | ||
| Q3 25 | $1.1B | $34.0M | ||
| Q2 25 | $926.6M | $45.3M | ||
| Q1 25 | $913.3M | $56.7M | ||
| Q4 24 | $868.3M | $68.0M | ||
| Q3 24 | $778.7M | $79.3M | ||
| Q2 24 | $726.2M | $90.7M |
| Q1 26 | $1.5B | — | ||
| Q4 25 | $1.4B | $130.3M | ||
| Q3 25 | $1.3B | $115.3M | ||
| Q2 25 | $1.3B | $104.7M | ||
| Q1 25 | $1.3B | $97.1M | ||
| Q4 24 | $1.3B | $92.1M | ||
| Q3 24 | $1.3B | $71.1M | ||
| Q2 24 | $1.3B | $48.5M |
| Q1 26 | $2.8B | — | ||
| Q4 25 | $2.6B | $216.3M | ||
| Q3 25 | $2.5B | $202.9M | ||
| Q2 25 | $2.3B | $194.9M | ||
| Q1 25 | $2.3B | $196.2M | ||
| Q4 24 | $2.3B | $213.3M | ||
| Q3 24 | $2.2B | $220.7M | ||
| Q2 24 | $2.1B | $205.0M |
| Q1 26 | — | — | ||
| Q4 25 | 0.76× | 0.17× | ||
| Q3 25 | 0.84× | 0.30× | ||
| Q2 25 | 0.70× | 0.43× | ||
| Q1 25 | 0.70× | 0.58× | ||
| Q4 24 | 0.65× | 0.74× | ||
| Q3 24 | 0.58× | 1.12× | ||
| Q2 24 | 0.55× | 1.87× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $14.4M |
| Free Cash FlowOCF − Capex | — | $14.4M |
| FCF MarginFCF / Revenue | — | 19.1% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $109.5M | $14.4M | ||
| Q3 25 | $28.0M | $9.7M | ||
| Q2 25 | $30.6M | $14.1M | ||
| Q1 25 | $22.1M | $3.6M | ||
| Q4 24 | $90.2M | $15.6M | ||
| Q3 24 | $25.1M | $11.0M | ||
| Q2 24 | $25.4M | $1.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% |
| Q1 26 | — | — | ||
| Q4 25 | 82.46× | — | ||
| Q3 25 | 45.27× | 1.10× | ||
| Q2 25 | 9.36× | 2.41× | ||
| Q1 25 | 13.06× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NTST
| Rental revenue (including reimbursable) | $54.0M | 95% |
| Other | $3.0M | 5% |
PBYI
Segment breakdown not available.
